v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Stockholders' Equity/(Deficit)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling interest
Total
Beginning balance at Dec. 31, 2024 $ (25,104,263) $ 91 $ 20,155,738 $ (45,426,099) $ 166,007 $ 1,317,756 $ (23,786,507)
Beginning balance (in shares) at Dec. 31, 2024   909,165          
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock to settle claim under Section 3(a)10 Settlement Agreement (see Note 9) 3,077,252 $ 11 3,077,241       3,077,252
Issuance of common stock to settle claim under Section 3(a)10 Settlement Agreement (see Note 9) (in shares)   114,830          
Issuance of common stock to settle share reset derivative liabilities (see Note 9) 1,712,005 $ 8 1,711,997       1,712,005
Issuance of common stock to settle share reset derivative liabilities (see Note 9) (in shares)   85,537          
Other comprehensive income 10,781       10,781   10,781
Net loss from continuing and discontinued operations (7,126,353)     (7,126,353)   43,804 (7,082,549)
Ending balance at Mar. 31, 2025 (27,430,578) $ 110 24,944,976 (52,552,452) 176,788 1,361,560 (26,069,018)
Ending balance (in shares) at Mar. 31, 2025   1,109,532          
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock to extinguish obligations to vendors and lenders under 3a10 plan 5,411,498 $ 31 5,411,467       5,411,498
Issuance of common stock to extinguish obligations to vendors and lenders under 3a10 plan (in shares)   314,674          
Issuance of common stock in connection with the conversion of convertible debt and accrued interest 3a9 7,740,915 $ 48 7,740,867       7,740,915
Issuance of common stock in connection with the conversion of convertible debt and accrued interest 3a9 (in shares)   477,842          
Issuance of common stock to BOD and employees 372,240 $ 5 372,235       372,240
Issuance of common stock to BOD and employees (in shares)   50,694          
Issuance of common stock in connection with stock subscription 805,000 $ 11 804,989       805,000
Issuance of common stock in connection with stock subscription (in shares)   114,323          
Issuance of common stock in connection with acquisition 3,141,478 $ 15 3,141,463       3,141,478
Issuance of common stock in connection with acquisition (in shares)   153,125          
Increase (decrease) in non-controlling interest from business combination           228,520 228,520
Issuance of common stock to vendors 132,895 $ 2 132,893       132,895
Issuance of common stock to vendors (in shares)   18,281          
Other comprehensive income from discontinuing operations (43,860)       (43,860)   (43,860)
Net loss from continuing and discontinued operations (4,657,171)     (4,657,171)   135,223 (4,521,948)
Ending balance at Jun. 30, 2025 (14,527,583) $ 222 42,548,890 (57,209,623) 132,928 1,725,303 (12,802,280)
Ending balance (in shares) at Jun. 30, 2025   2,238,471          
Beginning balance at Dec. 31, 2025 (1,526,982) $ 479 60,164,021 (61,671,149) (20,333) 3,102,445 1,575,463
Beginning balance (in shares) at Dec. 31, 2025   4,789,230          
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock in connection with the conversion of SEPA convertible debt 93,199 $ 1 93,198       93,199
Issuance of common stock in connection with the conversion of SEPA convertible debt (in shares)   11,548          
Issuance of commitment shares in connection with convertible debt 102,029 $ 1 102,028       102,029
Issuance of commitment shares in connection with convertible debt (in shares)   8,593          
Issuance of common stock in connection with share exchange agreement to settled accounts payable vendors 70,540 $ 1 70,539       70,540
Issuance of common stock in connection with share exchange agreement to settled accounts payable vendors (in shares)   6,974          
Issuance of common stock to BOD and employees 220,757 $ 3 220,754       220,757
Issuance of common stock to BOD and employees (in shares)   26,406          
Issuance of common stock in connection with equity method investment in Sun Solar 7,125,000 $ 47 7,124,953       7,125,000
Issuance of common stock in connection with equity method investment in Sun Solar (in shares)   468,750          
Fractional share adjustment due to reverse stock split (in shares)   1,410          
Other comprehensive income (560,036)       (560,036)   (560,036)
Net loss from continuing and discontinued operations (6,945,745)     (6,945,745)   276,000 (6,669,745)
Ending balance at Mar. 31, 2026 (1,421,238) $ 532 67,775,493 (68,616,894) (580,369) 3,378,445 1,957,207
Ending balance (in shares) at Mar. 31, 2026   5,312,911          
Increase (Decrease) in Stockholders' Equity              
Issuance of common stock in connection with the conversion of SEPA convertible debt 546,015 $ 7 546,008       546,015
Issuance of common stock in connection with the conversion of SEPA convertible debt (in shares)   72,551          
Issuance of commitment shares in connection with convertible debt 76,456 $ 1 76,455       76,456
Issuance of commitment shares in connection with convertible debt (in shares)   11,596          
Issuance of common stock in connection with the conversion of convertible debt and accrued interest 3a9 1,202,382 $ 22 1,202,360       1,202,382
Issuance of common stock in connection with the conversion of convertible debt and accrued interest 3a9 (in shares)   210,944          
Issuance of common stock in connection with share exchange agreement to settled accounts payable vendors 101,080 $ 1 101,079       101,080
Issuance of common stock in connection with share exchange agreement to settled accounts payable vendors (in shares)   13,662          
Issuance of common stock to BOD and employees 81,248 $ 1 81,247       81,248
Issuance of common stock to BOD and employees (in shares)   12,695          
Decrease in noncontrolling interest from sale of subsidiary equity           (1,548,970) (1,548,970)
Issuance of common stock in connection with acquisition 77,111 $ 2 77,109       77,111
Issuance of common stock in connection with acquisition (in shares)   12,500          
Fractional share adjustment due to reverse stock split (in shares)   9,304          
Release of cumulative translation adjustment on deconsolidation of GIX 778,060       778,060   778,060
Other comprehensive income from discontinuing operations (197,691)       $ (197,691)   (197,691)
Net loss from continuing and discontinued operations 12,750,643     12,750,643   522 12,751,164
Ending balance at Jun. 30, 2026 $ 13,994,066 $ 566 $ 69,859,751 $ (55,866,251)   $ 1,829,997 $ 15,824,063
Ending balance (in shares) at Jun. 30, 2026   5,656,163